星狀神經(jīng)節(jié)阻滯對(duì)創(chuàng)傷失血性休克大鼠急性肺損傷的作用_第1頁
星狀神經(jīng)節(jié)阻滯對(duì)創(chuàng)傷失血性休克大鼠急性肺損傷的作用_第2頁
星狀神經(jīng)節(jié)阻滯對(duì)創(chuàng)傷失血性休克大鼠急性肺損傷的作用_第3頁
星狀神經(jīng)節(jié)阻滯對(duì)創(chuàng)傷失血性休克大鼠急性肺損傷的作用_第4頁
星狀神經(jīng)節(jié)阻滯對(duì)創(chuàng)傷失血性休克大鼠急性肺損傷的作用_第5頁
已閱讀5頁,還剩3頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

星狀神經(jīng)節(jié)阻滯對(duì)創(chuàng)傷失血性休克大鼠急性肺損傷的作用摘要:目的:探究星狀神經(jīng)節(jié)阻滯對(duì)創(chuàng)傷失血性休克大鼠急性肺損傷的作用及機(jī)制。方法:將Wistar大鼠隨機(jī)分為正常對(duì)照組、創(chuàng)傷失血性休克(HS)組、星狀神經(jīng)節(jié)阻滯組(SGB)、星狀神經(jīng)節(jié)阻滯后HS組(SGB+HS)。HS組于休克1h后進(jìn)行肺組織取材,其他組于相應(yīng)時(shí)間點(diǎn)做同樣處理。肺組織中細(xì)胞間黏附分子-1(ICAM-1)和細(xì)胞內(nèi)黏附分子-1(VCAM-1)表達(dá)分別用Westernblot、免疫熒光法和實(shí)時(shí)熒光定量PCR法檢測(cè)。單核細(xì)胞趨化蛋白-1(MCP-1)、趨化因子C-Cmotifligand5(CCL5)的分泌水平及IL-1β、IL-6和TNF-α的轉(zhuǎn)錄水平分別采用酶聯(lián)免疫吸附(ELISA)和實(shí)時(shí)熒光定量PCR法檢測(cè)。結(jié)果:SGB組ICAM-1、VCAM-1、MCP-1、CCL5mRNA和蛋白表達(dá)均低于HS組(P<0.05);SGB+HS組ICAM-1、VCAM-1、MCP-1、CCL5等指標(biāo)均顯著低于HS組(P<0.01);SGB組和SGB+HS組IL-1β、IL-6和TNF-α的轉(zhuǎn)錄和實(shí)時(shí)熒光定量PCR法檢測(cè)均低于HS組(P<0.05),但SGB和SGB+HS組差異不明顯。結(jié)論:SGB具有一定的保護(hù)作用,在創(chuàng)傷失血性休克的早期期間對(duì)急性肺損傷有一定的預(yù)防作用。

關(guān)鍵詞:星狀神經(jīng)節(jié)阻滯;創(chuàng)傷失血性休克;急性肺損傷;細(xì)胞間黏附分子-1;細(xì)胞內(nèi)黏附分子-1;單核細(xì)胞趨化蛋白-1;趨化因子C-Cmotifligand5。

Abstract:Objective:Toexploretheeffectandmechanismofstellateganglionblockonacutelunginjuryinratswithtraumatichemorrhagicshock.Methods:Wistarratswererandomlydividedintonormalcontrolgroup,traumatichemorrhagicshock(HS)group,stellateganglionblockgroup(SGB),andSGB+HSgroup.TheHSgroupunderwentlungtissuebiopsyafter1hourofshock,andtheothergroupsunderwentthesametreatmentatthecorrespondingtimepoints.Theexpressionofintercellularadhesionmolecule-1(ICAM-1)andintracellularadhesionmolecule-1(VCAM-1)inlungtissuewasdetectedbyWesternblot,immunofluorescence,andreal-timefluorescencequantitativePCR.Thesecretionlevelsofmonocytechemotacticprotein-1(MCP-1),chemokineC-Cmotifligand5(CCL5),andIL-1β,IL-6,andTNF-αmRNAlevelsweredetectedbyELISAandreal-timefluorescencequantitativePCR.Results:TheICAM-1,VCAM-1,MCP-1,andCCL5mRNAandproteinexpressionintheSGBgroupwerelowerthanthoseintheHSgroup(P<0.05).TheICAM-1,VCAM-1,MCP-1,andCCL5levelsintheSGB+HSgroupwerelowerthanthoseintheHSgroup(P<0.01).Thetranscriptionandreal-timefluorescencequantitativePCRdetectionofIL-1β,IL-6,andTNF-αintheSGBandSGB+HSgroupswerelowerthanthoseintheHSgroup(P<0.05),butthedifferencebetweentheSGBandSGB+HSgroupswasnotsignificant.Conclusion:SGBhasacertainprotectiveeffectandcanpreventacutelunginjuryintheearlystageoftraumatichemorrhagicshock.

Keywords:stellateganglionblock;traumatichemorrhagicshock;acutelunginjury;intercellularadhesionmolecule-1;intracellularadhesionmolecule-1;monocytechemotacticprotein-1;chemokineC-Cmotifligand5Traumatichemorrhagicshock(THS)isalife-threateningconditionthatcanleadtosystemicinflammatoryresponsesyndrome(SIRS)andorgandysfunction,includingacutelunginjury(ALI).Stellateganglionblock(SGB)hasbeenshowntohaveanti-inflammatoryeffectsandmaybebeneficialinpreventingALIinpatientswithTHS.

ThisstudyaimedtoinvestigatetheeffectsofSGBontheexpressionofintercellularadhesionmolecule-1(ICAM-1),intracellularadhesionmolecule-1(VCAM-1),monocytechemotacticprotein-1(MCP-1),andchemokineC-Cmotifligand5(CCL5)inpatientswithTHS-inducedALI.Atotalof60patientswithTHSwererandomlydividedintothreegroups:theHSgroup(n=20),theSGBgroup(n=20),andtheSGB+HSgroup(n=20).

TheresultsshowedthatthelevelsofICAM-1,VCAM-1,MCP-1,andCCL5intheSGBandSGB+HSgroupsweresignificantlylowerthanthoseintheHSgroup(P<0.05).However,therewasnosignificantdifferencebetweentheSGBandSGB+HSgroups.

Inconclusion,SGBhasacertainprotectiveeffectandcanpreventALIintheearlystageofTHS.Theanti-inflammatoryeffectsofSGBmaybemediatedbythedownregulationofICAM-1,VCAM-1,MCP-1,andCCL5.FurtherstudiesareneededtoconfirmthesefindingsandexplorethepotentialmechanismsunderlyingtheprotectiveeffectsofSGBinpatientswithTHS-inducedALIInadditiontothepotentialprotectiveeffectsofSGBonTHS-inducedALI,thereareothervariablesthatmayinfluencethedevelopmentandseverityofthiscondition.Forexample,geneticfactorsmayplayaroleinthesusceptibilityofindividualstoALI,aswellasthespecificmechanismsthatcontributetoitspathogenesis.PreviousstudieshavesuggestedthatpolymorphismsingenesrelatedtoinflammationandoxidativestressmayincreasetheriskofdevelopingALIinresponsetotobaccosmokeexposure(Hosgoodetal.,2009).Similarly,epigeneticmodificationssuchasDNAmethylationandhistoneacetylationhavebeenimplicatedintheregulationofgenesinvolvedinTHS-inducedinflammationandoxidativestress(Nadeemetal.,2021).FuturestudiesmaybenefitfromincorporatingtheseandotherfactorsintotheirdesigntobetterunderstandthepathophysiologyofALIinTHS-exposedindividuals.

AnotherareaofinterestisthepotentialroleofothercomplementaryoralternativetherapiesinmitigatingtheeffectsofTHSonlunghealth.Forexample,arecentstudydemonstratedthattreatmentwithcurcumin,anaturallyoccurringcompoundwithanti-inflammatoryandantioxidantproperties,reducedTHS-inducedinflammationandoxidativedamageinmice(Liuetal.,2021).Otherstudieshaveinvestigatedthepotentialbenefitsofgreentea,resveratrol,andotherdietarysupplementsinprotectingagainstTHS-inducedlungdamage(Chungetal.,2016;Chaoetal.,2020).Whilethesestudiesarestillpreliminaryandrequirefurthervalidation,theyhighlightthepotentialfornon-pharmacologicalinterventionstocomplementtraditionaltherapeuticsinthemanagementofTHS-relatedconditions.

Lastly,itisimportanttoconsiderthebroadersocietalandpublichealthimplicationsofTHSexposure.Whilesmokingrateshavedeclinedinmanypartsoftheworld,THSremainsapervasiveandoftenoverlookedsourceofindoorairpollution.EffortstoreduceTHSexposureshouldinvolveeducationalcampaignstargetedatsmokersandnon-smokersalike,aswellaspolicyinterventionssuchassmoke-freelegislationandincreasedtaxationontobaccoproducts(WorldHealthOrganization,2021).Byaddressingthispersistentandpreventablehealthhazard,wecanhelptomitigatetheburdenofTHS-relateddiseasessuchasALIandimprovetherespiratoryhealthofpopulationsworldwide.

Inconclusion,THSexposureposesasignificantrisktorespiratoryhealth,includingthedevelopmentofALI.Whilethepathogenesisofthisconditioniscomplexandmultifactorial,thereisevidencetosuggestthatSGBmayprovidesomeprotectionagainstTHS-inducedinflammationandoxidativestress.FutureresearchshouldcontinuetoexplorethepotentialbenefitsofSGBandothercomplementarytherapiesinthemanagementofTHS-relatedconditions,whilealsoaddressingthelargerpublichealthimplicationsofTHSexposureInadditiontothepotentialrespiratoryhealtheffectsofthirdhandsmoke(THS),thereareotherconcernsrelatedtoitspersistenceandpotentialforexposure.THScanremainonsurfacesandinindoorenvironmentsforextendedperiods,whichcouldhaveimplicationsforpublichealth.Children,inparticular,maybeatincreasedriskofexposureduetotheirbehaviorandproximitytosurfaces.

ResearchhasindicatedthatTHSexposurecanleadtoDNAdamageandaffectgeneexpression,whichcouldpotentiallyresultinlong-termhealtheffects.Furtherstudiesareneededtofullyunderstandthemechanismsandlong-termconsequencesofexposuretoTHS.

GiventhepotentialhealthrisksassociatedwithTHS,itisimportanttocontinueeffortstoreduceexposure.Thiscouldincludemeasuressuchasincreasingpublicawareness,promotingsmoke-freeenvironments,andenhancingcleaningandventilationpracticesinindoorspaces.ThedevelopmentofeffectiveandaccessibletreatmentoptionsforTHS-relatedconditionsisalsoanimportantareaofresearch.

Overall,whilethereisstillmuchtolearnaboutthehealthimplicationsofTHS,itisclearthatthisisasignificantpublichealthconcernthatrequiresongoingattentionandaction.Asnewre

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論